Structured soft particulate matters for delivery of bioactive compounds in foods and functioning in the colon

被引:4
作者
Zhong, Qixin [1 ]
Reyes-Jurado, Fatima [1 ]
Calumba, Kriza Faye [1 ]
机构
[1] Univ Tennessee, Dept Food Sci, Knoxville, TN 37996 USA
基金
美国食品与农业研究所;
关键词
CONTROLLED-RELEASE; DRUG-DELIVERY; PHYSICOCHEMICAL PROPERTIES; LIPID NANOPARTICLES; OIL DROPLETS; SHELLAC; ALGINATE; ENCAPSULATION; EMULSIONS; CURCUMIN;
D O I
10.1039/d3sm00866e
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The present review discusses challenges, perspectives, and current needs of delivering bioactive compounds (BCs) using soft particulate matters (SPMs) for gut health. SPMs can entrap BCs for incorporation in foods, preserve their bioactivities during processing, storage, and gastrointestinal digestion, and deliver BCs to functioning sites in the colon. To enable these functions, physical, chemical, and biological properties of BCs are integrated in designing various types of SPMs to overcome environmental factors reducing the bioavailability and bioactivity of BCs. The design principles are applied using food grade molecules with the desired properties to produce SPMs by additionally considering the cost, sustainability, and scalability of manufacturing processes. Lastly, to make delivery systems practical, impacts of SPMs on food quality are to be evaluated case by case, and health benefits of functional foods incorporated with delivery systems are to be confirmed and must outweigh the cost of preparing SPMs. The colon structure, factors significant to gut health, the fate of diet digesta entering the colon, and the functions of delivery systems in the colon.
引用
收藏
页码:277 / 293
页数:17
相关论文
共 172 条
[81]   Food as Treatment of Inflammatory Bowel Diseases [J].
Maldonado-Contreras, Ana .
INFECTION AND IMMUNITY, 2022, 90 (05)
[82]   Polyphenols:: food sources and bioavailability [J].
Manach, C ;
Scalbert, A ;
Morand, C ;
Rémésy, C ;
Jiménez, L .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 79 (05) :727-747
[83]   Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis [J].
Manolis, Antonis A. ;
Manolis, Theodora A. ;
Melita, Helen ;
Manolis, Antonis S. .
CURRENT MEDICINAL CHEMISTRY, 2022, 29 (23) :4050-4077
[84]  
Marley AR, 2016, INT J MOL EPIDEMIOL, V7, P105
[85]   Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer [J].
Marmol, Ines ;
Sanchez-de-Diego, Cristina ;
Pradilla Dieste, Alberto ;
Cerrada, Elena ;
Jesus Rodriguez Yoldi, Maria .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01)
[86]   Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD [J].
Martyniak, Adrian ;
Medynska-Przeczek, Aleksandra ;
Wedrychowicz, Andrzej ;
Skoczen, Szymon ;
Tomasik, Przemyslaw J. .
BIOMOLECULES, 2021, 11 (12)
[87]   Recent advances in modulation of cardiovascular diseases by the gut microbiota [J].
Masenga, Sepiso K. ;
Hamooya, Benson ;
Hangoma, Joy ;
Hayumbu, Valerie ;
Ertuglu, Lale A. ;
Ishimwe, Jeanne ;
Rahman, Sharla ;
Saleem, Mohammad ;
Laffer, Cheryl L. ;
Elijovich, Fernando ;
Kirabo, Annet .
JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (11) :952-959
[88]  
McClements D. J., 2015, Food emulsions: principles, practices, and techniques
[89]   Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate and toxicity of organic and inorganic food-grade nanoparticles [J].
McClements, David Julian ;
Xiao, Hang .
NPJ SCIENCE OF FOOD, 2017, 1 (01)